|
| 36939530 | Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer. | Clin Cancer Res | 2023 |
| 37856213 | Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 37168382 | PARP inhibitors in metastatic prostate cancer. | Front Oncol | 2023 |
| 37477521 | Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells. | Oncotarget | 2023 |
| 37330052 | Fragmentomic analysis of circulating tumor DNA-targeted cancer panels. | Ann Oncol | 2023 |
| 34519889 | ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. | Eur J Nucl Med Mol Imaging | 2022 |
| 35617646 | Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma. | J Clin Oncol | 2022 |
| 35468853 | Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer. | Biomark Res | 2022 |
| 35654785 | A role for microfluidic systems in precision medicine. | Nat Commun | 2022 |
| 36509074 | NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. | J Natl Compr Canc Netw | 2022 |
| 36260524 | Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer. | Clin Cancer Res | 2022 |
| 36050516 | Reversible epigenetic alterations regulate class I HLA loss in prostate cancer. | Commun Biol | 2022 |
| 36253482 | Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone. | NPJ Genom Med | 2022 |
| 36317634 | A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer. | J Clin Invest | 2022 |
| 36251389 | The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. | Cancer Res | 2022 |
| 35226381 | Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment. | Prostate | 2022 |
| 35159026 | Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment. | Cancers (Basel) | 2022 |
| 35277461 | Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). | J Immunother Cancer | 2022 |
| 34878806 | Reply to M. K. Bos et al. | J Clin Oncol | 2022 |
| 35272673 | SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples. | Clin Epigenetics | 2022 |
| 34897347 | Volumeless reagent delivery: a liquid handling method for adding reagents to microscale droplets without increasing volume. | Lab Chip | 2022 |
| 34280123 | AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer. | Endocr Relat Cancer | 2021 |
| 33545689 | NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. | J Natl Compr Canc Netw | 2021 |
| 33741442 | Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial. | Ann Oncol | 2021 |
| 33849963 | Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. | Clin Cancer Res | 2021 |
| 33604999 | Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma. | Mol Oncol | 2021 |
| 34865122 | BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity. | Nucleic Acids Res | 2021 |
| 34554200 | Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer. | JAMA Oncol | 2021 |
| 34581895 | Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling. | Med Oncol | 2021 |
| 34548481 | Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures. | NPJ Genom Med | 2021 |
| 34197212 | Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer. | J Clin Oncol | 2021 |
| 32255253 | Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer. | Mol Oncol | 2020 |
| 32031899 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma. | J Clin Oncol | 2020 |
| 32097091 | Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003. | J Clin Oncol | 2020 |
| 31983266 | Pairing Microwell Arrays with an Affordable, Semiautomated Single-Cell Aspirator for the Interrogation of Circulating Tumor Cell Heterogeneity. | SLAS Technol | 2020 |
| 33034643 | A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation. | Integr Biol (Camb) | 2020 |
| 33245727 | Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer. | Oncotarget | 2020 |
| 32897830 | Exploring Spatial-Temporal Changes in <sup>18</sup>F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide. | J Clin Oncol | 2020 |
| 30582152 | Are liquid biopsies ready for primetime? | Cancer | 2019 |
| 31300353 | Understanding dynamic interactions in the prostate tumor microenvironment. | Urol Oncol | 2019 |
| 31180792 | Automated System for Small-Population Single-Particle Processing Enabled by Exclusive Liquid Repellency. | SLAS Technol | 2019 |
| 31411020 | Centrifugation-Assisted Immiscible Fluid Filtration for Dual-Bioanalyte Extraction. | Anal Chem | 2019 |
| 31511828 | Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides. | Am J Clin Exp Urol | 2019 |
| 31085757 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2019 |
| 30747897 | Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches. | J Urol | 2019 |
| 30458979 | Development and translation of novel therapeutics targeting tumor-associated macrophages. | Urol Oncol | 2019 |
| 29339080 | Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms. | J Urol | 2018 |
| 30131982 | Surface topography and hydrophilicity regulate macrophage phenotype in milled microfluidic systems. | Lab Chip | 2018 |
| 30334061 | Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extraction. | Lab Chip | 2018 |
| 29669286 | Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration. | Cell Rep | 2018 |